Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, Churchill Hospital, Oxford, United Kingdom.
J Infect Dis. 2019 Apr 16;219(9):1483-1489. doi: 10.1093/infdis/jiy673.
Artemisinin resistance in falciparum malaria is associated with kelch13 propeller mutations, reduced ring stage parasite killing, and, consequently, slow parasite clearance. We assessed how parasite age affects parasite clearance in artemisinin resistance.
Developmental stages of Plasmodium falciparum parasites on blood films performed at hospital admission and their kelch13 genotypes were assessed for 816 patients enrolled in a multinational clinical trial of artemisinin combination therapy.
Early changes in parasitemia level (ie, 0-6 hours after admission) were determined mainly by modal stage of asexual parasite development, whereas the subsequent log-linear decline was determined mainly by kelch13 propeller mutations. Older circulating parasites on admission were associated with more-rapid parasite clearance, particularly in kelch13 mutant infections. The geometric mean parasite clearance half-life decreased by 11.6% (95% CI 3.4%-19.1%) in kelch13 wild-type infections and by 30% (95% CI 17.8%-40.4%) in kelch13 mutant infections as the mean age of circulating parasites rose from 3 to 21 hours.
Following the start of antimalarial treatment, ongoing parasite sequestration and schizogony both affect initial changes in parasitemia. The greater dependency of parasite clearance half-life on parasite age in artemisinin resistant infections is consistent with ring stage resistance and consequent parasite clearance by sequestration. The stage of parasite development should be incorporated in individual assessments of artemisinin resistance.
恶性疟原虫对青蒿素的抗药性与 kelch13 推进器突变、减少环状体寄生虫杀伤以及随后的寄生虫清除率降低有关。我们评估了寄生虫年龄如何影响青蒿素耐药性中的寄生虫清除。
在一项多中心青蒿素联合疗法临床试验中,对 816 名患者入院时的血片进行了疟原虫发育阶段评估及其 kelch13 基因型分析。
寄生虫血症水平的早期变化(即入院后 0-6 小时)主要取决于无性体寄生虫发育的模态阶段,而随后的对数线性下降主要取决于 kelch13 推进器突变。入院时循环寄生虫的年龄越大,寄生虫清除越快,尤其是在 kelch13 突变感染中。kelch13 野生型感染中寄生虫清除半衰期的几何平均减少 11.6%(95%CI 3.4%-19.1%),kelch13 突变型感染中寄生虫清除半衰期的几何平均减少 30%(95%CI 17.8%-40.4%),随着循环寄生虫的平均年龄从 3 小时增加到 21 小时。
在开始抗疟治疗后,持续的寄生虫隔离和裂殖子生成均会影响寄生虫血症的初始变化。在青蒿素耐药感染中,寄生虫清除半衰期对寄生虫年龄的依赖性更大,这与环状体耐药和随后的寄生虫隔离清除一致。在个体评估青蒿素耐药性时,应将寄生虫发育阶段纳入其中。